Relative Intelligence · Medical Devices

How Boston Scientific (BSX) compares with the whole market and its popular alternatives
Built by QuantCommons' quantitative engine, this page is about relative opportunity, not data on BSX alone. It places BSX (Boston Scientific Corporation) against 20+ popular alternatives, its neighboring categories and the entire market of over 10,000 U.S.-listed stocks and ETFs, and surfaces what has done better on consistent outperformance, return for the risk taken, behavior in real market crashes and diversification. The result is a clearer view of where BSX stands in the market, and of the alternatives worth a closer look.
Period covered: BSX's full trading record, from May 1992 through September 2026. All returns include reinvested dividends. Data as of October 20, 2026.
Data as of October 20, 2026. Full tables and charts read best on a larger screen.
On this page12 sections
Key findings
- Right nowBSX has gone against the market, falling 25.3% over the past 6 months while the S&P 500 rose 9.1%. The slide is BSX's own: it is 57.9% below its high, against 1.3% for the S&P 500. At a glance ↓
- Stock or market?BSX rose 4.1% over the past 3 months, 3.3 points behind the medical devices ETF IHI (iShares U.S. Medical Devices ETF), which rose 7.5%. The S&P 500 rose 3.9%. Its medical device peers did not move as one over the past 3 months: ISRG (Intuitive Surgical) rose 24.0%, while SYK (Stryker) fell 4.3%.
- Past 1 to 3 yearsOver the past year, BSX fell 54.7% while the S&P 500 rose 15.8%. The same gap shows up over 3 years (8.9% against 89.3%). BSX led its medical device peers in 2023, then fell behind JNJ (Johnson & Johnson) and ABT (Abbott Laboratories) in 2025. By year ↓
- Long termBSX turned $10,000 into $19,800 over the past decade, against $42,100 in the S&P 500. Year by year, BSX has outpaced the S&P 500 34% of the time since 1997. Growth of $10,000 ↓
- In a crashAcross seven sell-offs, BSX has typically fallen 1.2 times as far as the S&P 500. Crash tests ↓
- DiversificationOver 10 years BSX took more of the market's losses than of its gains: in the S&P 500's rising months it gained 76% as much as the index, and in falling months it lost 1.1 times as much, with a beta of 0.72. Market capture ↓
- Better options
- Nearby categories and themes
- CAH (Cardinal Health, health care distribution) and ABBV (AbbVie, pharmaceuticals) earned more than BSX with less volatility over the past 5 years. CAH returned 42.1% a year at 24.7% volatility, against 0.5% a year at 26.6%.
- Whole market
- 983 of the 3,633 stocks and funds worth at least $500 million earned more than BSX with less volatility over the past 5 years, among them VTI (Vanguard Morningstar Total Stock Market ETF), VOO (Vanguard S&P 500 ETF) and BRK-B (Berkshire Hathaway).
How much would $10,000 in BSX have grown?
This chart tracks a hypothetical $10,000 investment in BSX over the past 29 years, with dividends reinvested, alongside the same amount in the S&P 500, investments that ended ahead of BSX over the same span and BSX's popular alternatives, among those that traded for the entire period. A second view covers the past 5 years, the period the better options further down the page are judged on. It shows not only where each investment ended up but also how smooth or uneven the path was.
- $10,000 invested in BSX at the end of September 1997 would have grown to $31,631 by September 2026, less than the $132,907 it would have become in SPY, an S&P 500 fund.
- All eight other investments on the chart ended ahead of BSX, and UNH finished highest, at $772,802.
Choose a period
From the end of September 1997 to the end of September 2026. The scale is logarithmic, so equal steps up the chart are equal percentage gains. Hover over a fund in the key to pick out its line. 856 of the 1,042 stocks and funds worth at least $500 million that traded the whole period ended ahead of BSX; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- UNH$772,802+7,628% total · +16.2% a year
- SYK$323,233+3,132% total · +12.7% a year
- TMO$235,386+2,254% total · +11.5% a year
- ICUI$226,694+2,167% total · +11.4% a year
- JNJ$189,226+1,792% total · +10.7% a year
- SPY (S&P 500)$132,907+1,229% total · +9.3% a year
- ABT$130,278+1,203% total · +9.3% a year
- HAE$111,549+1,015% total · +8.7% a year
- MDT$61,200+512% total · +6.4% a year
- BSX$31,631+216% total · +4.1% a year
From the end of September 2021 to the end of September 2026. Hover over a fund in the key to pick out its line. 2,512 of the 3,628 stocks and funds worth at least $500 million that traded the whole period ended ahead of BSX; the chart shows 5, closest alternatives first. The other 3 lines are popular alternatives, shown for context.
- SPY (S&P 500)$19,000+90.0% total · +13.7% a year
- JNJ$18,849+88.5% total · +13.5% a year
- HCA$18,335+83.3% total · +12.9% a year
- HAE$14,917+49.2% total · +8.3% a year
- ISRG$12,270+22.7% total · +4.2% a year
- TMO$11,986+19.9% total · +3.7% a year
- SYK$11,008+10.1% total · +1.9% a year
- BDX$10,410+4.1% total · +0.8% a year
- UNH$10,283+2.8% total · +0.6% a year
- BSX$10,060+0.6% total · +0.1% a year
BSX at a glance
This section summarizes the key facts about the stock, its returns over periods from one to ten years and the risk it has carried, with dividends reinvested throughout. These figures serve as the baseline for every comparison that follows.
- BSX is still 57.9% below its all-time high.
- BSX's deepest decline since it began trading in 1992 was 89.1%, from April 2004 to July 2012. It took about nine years from the low to climb back to its old high.
- Over 29 full calendar years, BSX's best was 2013, when it returned 110%, and its worst was 2000, when it lost 37.5%. It lost money in 11 of those years.
The company
- Market value
- $66B
- Industry
- Medical - Devices
- Price history from
- May 1992
Returns
- Past 1 year
- −54.7%total return
- Past 3 years
- −8.9%−3.1% a year
- Past 5 years
- +2.5%+0.5% a year
- Past 10 years
- +98.1%+7.1% a year
- Best calendar year
- +110%2013
- Worst calendar year
- −37.5%2000
- Losing years
- 11 of 29full calendar years
Risk
- Volatility
- 26.6%typical yearly swing, 5 years
- Sharpe ratio
- 0.15return per unit of risk, 5 years
- Worst decline ever
- −89.1%Apr 2004 to Jul 2012
- From its all-time high
- −57.9%below the peak
BSX against the whole market
Where BSX ranks among every stock and fund, and what across the market has done better.
How does BSX rank among all stocks?
This section ranks BSX on return, volatility, risk-adjusted return and worst decline against every stock worth at least $300 million with enough history. Where the comparisons with its popular alternatives show how BSX stacks up against its peers, these rankings show where it stands in the market as a whole.
- BSX's 1-year return ranks in the bottom 4% of the 3,287 stocks worth at least $300 million with 1 year of history.
- BSX is among the steadier stocks: its price swings rank in the top 16% of the 2,893 stocks worth at least $300 million, where the top is the calmest.
Ranked against U.S.-listed stocks worth at least $300M that have enough history for each measure, so the count changes from row to row; smaller stocks are left out. Lower volatility and smaller declines rank higher.
| Measure | BSX | Rank | Standing |
|---|---|---|---|
| 1-year return | −54.7% | 3,148 of 3,287 | bottom 5% |
| 3-year return | −8.9% | 2,457 of 3,017 | bottom 20% |
| 5-year return | +2.5% | 1,705 of 2,893 | bottom 42% |
| 10-year return | +98.1% | 1,347 of 2,202 | bottom 40% |
| Volatility, 5 years | 26.6% | 449 of 2,893 | top 16% |
| Sharpe ratio, 5 years | 0.15 | 1,978 of 2,893 | bottom 33% |
| Worst decline, past 10 years | −61.6% | 945 of 2,187 | top 43% |
What has beaten BSX on both return and risk?
Each dot is an investment, placed by how much it earned a year over the past 5 years (higher is better) and how much its price swung, its volatility (further left is calmer). BSX sits where the dashed lines cross. Anything in the green box above and to the left earned more than BSX with smaller swings, a better trade-off over this period on both counts. Past results are no promise, but a name in the box is worth a closer look.
- 234 stocks and 749 ETFs worth at least $500 million sit in the green region: each earned more than BSX over the past 5 years with smaller price swings. That is 27% of the 3,633 screened.
- Among those with at least half BSX's swings, CAH has the best return for its risk: 42.1% a year at 24.7% volatility, 7% less than BSX's 26.6%, and a Sharpe ratio (return above cash per unit of volatility) of 1.55 against 0.15 for BSX.
- Among BSX's popular alternatives, JNJ and BDX are in the region. JNJ earned 12.7% a year against 0.5% a year for BSX, at 17.9% volatility, 33% less than BSX's 26.6%.
Annual return is the annualized total return with dividends reinvested, and volatility the annualized swing in daily prices, both over 5 years. Labeled dots are the strongest picks from the table below and the names called out above, colored by how close they sit to BSX; faint dots are 92 more of the 983 in the green region (the strongest, one per fund family). 3,633 stocks and funds worth at least $500 million were screened. Hover over a dot for its figures.
- Popular alternatives
- Same and neighboring categories, and shared themes
- The whole market
- Others in the green region
Is there a better investment than BSX?
Investments that beat BSX over the past 5 years on return, volatility, drawdowns, consistency, crash losses or fees, from its popular alternatives out to the whole market.
- Among BSX's popular alternatives, JNJ and BDX earned more than BSX with less volatility over the past 5 years. JNJ returned 12.7% a year at 17.9% volatility, against 0.5% a year at 26.6%.
- Looking beyond its popular alternatives, CAH (health care distribution) and ABBV (pharmaceuticals) earned more than BSX with less volatility over the past 5 years. CAH returned 42.1% a year at 24.7% volatility, against 0.5% a year at 26.6%.
- Across the whole market, 983 of the 3,633 stocks and funds worth at least $500 million earned more than BSX with less volatility over the past 5 years, among them VTI, VOO and BRK-B.
How this works
The table below lists investments that beat BSX over the past 5 years on at least one of these measures: a higher annual return with lower volatility, a higher annual return at similar volatility, a similar return with lower volatility, a higher Sharpe ratio with a smaller worst decline, a higher total return in most periods from 3 months to 10 years, or smaller losses in recent market crashes. It checks BSX's popular alternatives first, then the rest of its own and neighboring categories, then every stock and fund worth at least $500 million, and shows the strongest few in each group. The full list of those with a higher return and lower volatility than BSX follows the table.
Annual return is the annualized total return with dividends reinvested. Annual return, volatility and the Sharpe ratio cover 5 years; the worst decline covers the past 10 years. Green marks a better figure than BSX's. "On the frontier" means no other option shown or tested earned more with less volatility. Funds that hold the same thing are shown once. Beyond the popular alternatives, nothing with more than 1.5× BSX's volatility counts as better.
These figures cover the past 5 years. Green marks a better figure than BSX's.
| Investment | Why it is better | Past 5 years | Downside | Long run | Fit | ||||
|---|---|---|---|---|---|---|---|---|---|
| Annual return?higher is better | Volatility?lower is calmer | Sharpe?return per unit of risk | Worst decline?past 10 years | 10Y returntotal | Corr. with BSX?lower diversifies more | Expenseper year | |||
| +0.5% | 26.6% | 0.15 | −61.6% | +98.1% | 1.00 | — | |||
| +12.7% | 17.1% | 0.79 | −33.7% | +321% | 0.37 | 0.09% | |||
| Popular alternativesbest 6 shownThe investments people most often weigh against BSX. 14 of 24 passed at least one test. | |||||||||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +12.7% | 17.9% | 0.76 | −27.4% | +196% | 0.07 | — | ||
| Higher return, lower volatilityHigher return in most periods | +2.3% | 24.1% | 0.22 | −39.9% | +71.4% | 0.21 | — | ||
| Higher Sharpe, smaller worst declineHigher return in most periods | +14.1% | 30.1% | 0.59 | −54.7% | +513% | 0.53 | — | ||
| Higher Sharpe, smaller worst declineHigher return in most periods | +5.2% | 34.6% | 0.32 | −49.9% | +478% | 0.56 | — | ||
| Higher return in most periods | +1.1% | 32.1% | 0.20 | −61.4% | +241% | -0.03 | — | ||
| Higher return in most periods | +2.9% | 27.8% | 0.24 | −40.9% | +366% | 0.32 | — | ||
| Same and neighboring categories, and shared themesbest 6 shownEverything else in Medical Devices and the categories next to it (Health Care Facilities, Pharmaceuticals, Life Sciences Tools, Health Care Distribution), plus BSX's specific themes. 32 of 57 passed at least one test. | |||||||||
| On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +42.1% | 24.7% | 1.55 | −46.1% | +349% | 0.32 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +26.1% | 23.4% | 1.11 | −45.1% | +603% | 0.05 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +38.7% | 25.0% | 1.44 | −38.1% | +586% | 0.29 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +17.1% | 20.7% | 0.87 | −26.8% | +226% | 0.27 | — | ||
EHCEncompass Health Corporation · Health Care Facilities | Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +18.4% | 26.8% | 0.77 | −39.5% | +340% | 0.41 | — | |
| Higher return in most periodsSmaller losses in recent crashes | −3.8% | 29.1% | 0.01 | −43.8% | +232% | 0.25 | — | ||
| The whole marketbest 8 shownEvery other stock and fund worth at least $500 million. 1,957 of 3,552 passed at least one test. | |||||||||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +14.7% | 16.8% | 0.91 | −37.0% | +204% | 0.33 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +12.1% | 13.7% | 0.90 | −36.8% | +235% | 0.38 | 0.03% | ||
| On the frontierHigher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +3.8% | 0.3% | 13.25 | −0.3% | — | 0.23 | 0.09% | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +17.7% | 18.9% | 0.96 | −26.4% | +213% | 0.23 | 0.40% | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +5.1% | 18.3% | 0.37 | −23.8% | +145% | 0.33 | — | ||
| Higher return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +10.4% | 14.1% | 0.78 | −31.7% | +258% | 0.42 | 0.04% | ||
| Higher return, similar volatilityHigher Sharpe, smaller worst declineHigher return in most periodsSmaller losses in recent crashes | +12.3% | 25.3% | 0.59 | −42.1% | +323% | 0.30 | — | ||
SUBiShares Short-Term National Muni Bond ETF · Municipal Bonds | Similar return, lower volatilityHigher Sharpe, smaller worst declineHigher return in most periods | +1.4% | 1.7% | 0.85 | −9.4% | +15.6% | 0.28 | 0.07% | |
What these numbers mean for BSX
- Annual return
- BSX returned 0.5% a year over the past 5 years with dividends reinvested, against 12.7% a year for the S&P 500. At that pace, $10,000 became about $10,200. Annual return is the steady yearly rate that would produce the same total result, so investments held over the same span compare fairly. Guide: What is performance and return? →
- Volatility
- BSX's volatility over the past 5 years was 26.6%, 1.5 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, BSX's return lands within 26.6% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump. Guide: Understanding and measuring risk (volatility) →
- Sharpe ratio
- BSX's Sharpe ratio over the past 5 years was 0.15, against 0.79 for the S&P 500, so BSX earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings. Guide: Balancing reward with risk (Sharpe ratio) →
- Worst decline
- BSX's worst fall from a peak to a low over the past 10 years was 61.6%, against 33.7% for the S&P 500. Losses and gains are not symmetric: climbing back from a 61.6% fall takes a 160% gain. Guide: Market crash risk and tail risk →
- Correlation
- Over the past 5 years, BSX's monthly returns had a correlation of 0.37 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against BSX instead: the lower it is, the more that option would diversify a BSX holding. Guide: Correlation and diversification →
Show all 983 stocks and funds worth at least $500 million that earned more than BSX with less volatility
Out of 3,633 tested over 5 years. The strongest 100 are listed, best first, with funds that hold the same thing listed once.
| # | Investment | Found in | Annual return | Volatility | Sharpe | Worst decline | 10Y return | Corr. with BSX | Expense |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Whole market | +14.7% | 16.8% | 0.91 | −37.0% | +204% | 0.33 | — | |
| 2 | Whole market | +12.1% | 13.7% | 0.90 | −36.8% | +235% | 0.38 | 0.03% | |
| 3 | Whole market | +3.8% | 0.3% | 13.25 | −0.3% | — | 0.23 | 0.09% | |
| 4 | Whole market | +17.7% | 18.9% | 0.96 | −26.4% | +213% | 0.23 | 0.40% | |
| 5 | Whole market | +5.1% | 18.3% | 0.37 | −23.8% | +145% | 0.33 | — | |
| 6 | Whole market | +10.4% | 14.1% | 0.78 | −31.7% | +258% | 0.42 | 0.04% | |
| 7 | Whole market | +9.7% | 14.3% | 0.72 | −33.4% | +252% | 0.32 | 0.06% | |
| 8 | Whole market | +11.3% | 18.8% | 0.67 | −38.4% | +170% | 0.18 | — | |
| 9 | Whole market | +13.9% | 18.5% | 0.80 | −34.0% | +446% | 0.32 | — | |
| 10 | Whole market | +17.3% | 18.2% | 0.97 | −40.0% | +352% | 0.17 | — | |
| 11 | Whole market | +9.3% | 19.2% | 0.56 | −30.1% | +344% | 0.30 | — | |
| 12 | JAAAJanus Henderson AAA CLO ETF · CLO Bonds | Whole market | +5.1% | 1.7% | 2.98 | −2.6% | — | 0.21 | 0.20% |
| 13 | Whole market | +7.5% | 18.0% | 0.50 | −37.4% | +132% | 0.21 | — | |
| 14 | Whole market | +12.4% | 20.2% | 0.68 | −32.9% | +185% | 0.15 | — | |
| 15 | Whole market | +4.4% | 20.9% | 0.31 | −35.8% | +245% | 0.43 | — | |
| 16 | Whole market | +12.0% | 18.8% | 0.70 | −30.9% | +114% | 0.13 | — | |
| 17 | ATOAtmos Energy Corporation · Gas Utilities | Whole market | +14.9% | 18.4% | 0.85 | −32.9% | +194% | 0.27 | — |
| 18 | CHTChunghwa Telecom Co., Ltd. · Integrated Telecommunications | Whole market | +7.7% | 13.3% | 0.63 | −23.8% | +101% | 0.14 | — |
| 19 | Whole market | +6.1% | 20.0% | 0.40 | −31.6% | +270% | 0.33 | — | |
| 20 | HDViShares Core High Dividend ETF · US Dividend Equity | Whole market | +12.9% | 13.0% | 1.00 | −37.0% | +172% | 0.38 | 0.08% |
| 21 | WECWEC Energy Group, Inc. · Electric Utilities | Whole market | +7.2% | 19.0% | 0.46 | −32.3% | +159% | 0.18 | — |
| 22 | USMViShares MSCI USA Min Vol Factor ETF · US Low-Volatility Equity | Whole market | +7.6% | 12.3% | 0.66 | −33.1% | +176% | 0.46 | 0.15% |
| 23 | AEEAmeren Corporation · Electric Utilities | Whole market | +7.9% | 19.4% | 0.49 | −29.1% | +192% | 0.16 | — |
| 24 | XLUState Street Utilities Select Sector SPDR ETF · Utilities Equity | Whole market | +7.8% | 17.4% | 0.52 | −36.0% | +138% | 0.25 | 0.08% |
| 25 | SDYState Street SPDR S&P Dividend ETF · US Dividend Equity | Whole market | +7.6% | 14.0% | 0.59 | −36.7% | +157% | 0.37 | 0.35% |
| 26 | Whole market | +11.5% | 17.5% | 0.71 | −35.0% | +302% | 0.36 | 0.03% | |
| 27 | EVRGEvergy, Inc. · Electric Utilities | Whole market | +9.5% | 18.9% | 0.57 | −38.8% | +109% | 0.12 | — |
| 28 | Whole market | +12.8% | 16.9% | 0.80 | −34.0% | +324% | 0.37 | 0.03% | |
| 29 | XLPState Street Consumer Staples Select Sector SPDR ETF · Consumer Staples | Whole market | +7.2% | 13.8% | 0.57 | −24.5% | +121% | 0.41 | 0.08% |
| 30 | Popular alternative | +12.7% | 17.9% | 0.76 | −27.4% | +196% | 0.07 | — | |
| 31 | Whole market | +20.8% | 22.6% | 0.96 | −25.7% | +508% | 0.39 | — | |
| 32 | Whole market | +13.4% | 17.1% | 0.82 | −29.6% | +274% | 0.43 | — | |
| 33 | MOATVanEck Morningstar Wide Moat ETF · US Large-Cap Equity | Whole market | +9.1% | 18.4% | 0.57 | −33.3% | +276% | 0.44 | 0.46% |
| 34 | THGThe Hanover Insurance Group, Inc. · Property & Casualty Insurance | Whole market | +14.4% | 22.9% | 0.70 | −40.1% | +291% | 0.09 | — |
| 35 | Whole market | +17.3% | 24.3% | 0.78 | −43.6% | +537% | 0.40 | — | |
| 36 | IDAIDACORP, Inc. · Electric Utilities | Whole market | +8.8% | 19.2% | 0.54 | −34.3% | +141% | 0.10 | — |
| 37 | Same or nearby category | +42.1% | 24.7% | 1.55 | −46.1% | +349% | 0.32 | — | |
| 38 | SPLVInvesco S&P 500 Low Volatility ETF · US Low-Volatility Equity | Whole market | +5.5% | 12.6% | 0.49 | −36.3% | +129% | 0.41 | 0.25% |
| 39 | IWXiShares Russell Top 200 Value ETF · Broad Market | Whole market | +12.7% | 13.8% | 0.94 | −35.8% | +221% | 0.42 | 0.20% |
| 40 | Whole market | +12.8% | 22.9% | 0.64 | −36.4% | +429% | 0.52 | — | |
| 41 | DXJWisdomTree Japan Hedged Equity Fund · International Equity | Whole market | +26.6% | 19.1% | 1.34 | −39.1% | +428% | 0.17 | 0.48% |
| 42 | LVHIFranklin International Low Volatility High Dividend Index ETF · International Equity | Whole market | +17.0% | 11.1% | 1.48 | −32.4% | +194% | 0.29 | 0.40% |
| 43 | FTLSFirst Trust Long/Short Equity ETF · Broad Market | Whole market | +10.2% | 10.4% | 0.99 | −20.6% | +158% | 0.39 | 0.95% |
| 44 | PTLCPacer Trendpilot US Large Cap ETF · Broad Market | Whole market | +9.5% | 11.8% | 0.83 | −26.6% | +188% | 0.26 | 0.60% |
| 45 | VRIGInvesco Variable Rate Investment Grade ETF · Bonds | Whole market | +4.7% | 1.3% | 3.51 | −13.1% | +40.5% | 0.19 | 0.30% |
| 46 | BALTInnovator Defined Wealth Shield ETF · Crypto | Whole market | +6.3% | 3.3% | 1.85 | −4.9% | — | 0.38 | 0.69% |
| 47 | Whole market | +19.5% | 25.2% | 0.84 | −55.8% | +238% | 0.26 | — | |
| 48 | Whole market | +17.4% | 22.9% | 0.82 | −31.4% | +685% | 0.33 | — | |
| 49 | Whole market | +8.2% | 16.4% | 0.57 | −36.0% | +140% | 0.28 | 0.05% | |
| 50 | SRSpire Inc. · Gas Utilities | Whole market | +9.7% | 21.2% | 0.55 | −39.5% | +98.3% | 0.30 | — |
| 51 | RLIRLI Corp. · Property & Casualty Insurance | Whole market | +8.1% | 23.9% | 0.45 | −43.5% | +206% | 0.19 | — |
| 52 | AORiShares Core 60/40 Balanced Allocation ETF · Multi-Asset | Whole market | +6.4% | 10.7% | 0.64 | −23.0% | +118% | 0.34 | 0.20% |
| 53 | Whole market | +14.5% | 23.0% | 0.71 | −35.1% | +553% | 0.19 | 0.18% | |
| 54 | Whole market | +12.4% | 23.8% | 0.61 | −41.0% | +541% | 0.59 | — | |
| 55 | Whole market | +21.0% | 23.4% | 0.94 | −42.9% | +242% | 0.27 | — | |
| 56 | ACWViShares MSCI Global Min Vol Factor ETF · International | Whole market | +6.3% | 10.3% | 0.65 | −28.8% | +116% | 0.47 | 0.20% |
| 57 | CWBState Street SPDR Bloomberg Convertible Securities ETF · Corporate Bonds | Whole market | +3.7% | 13.7% | 0.34 | −32.1% | +178% | 0.14 | 0.40% |
| 58 | Whole market | +18.6% | 24.3% | 0.83 | −52.0% | +317% | 0.35 | — | |
| 59 | FLRTPacer Aristotle Pacific Floating Rate High Income ETF · Financials | Whole market | +6.0% | 2.3% | 2.55 | −21.0% | +58.0% | 0.31 | 0.60% |
| 60 | Whole market | +19.6% | 24.9% | 0.85 | −24.9% | +266% | 0.27 | — | |
| 61 | DHSWisdomTree U.S. High Dividend Fund · Dividend & Income | Whole market | +12.0% | 13.9% | 0.89 | −37.4% | +156% | 0.32 | 0.38% |
| 62 | Whole market | +22.8% | 24.9% | 0.95 | −30.5% | +200% | 0.17 | — | |
| 63 | IHDGWisdomTree International Hedged Quality Dividend Growth Fund · International | Whole market | +7.6% | 14.9% | 0.57 | −29.2% | +163% | 0.39 | 0.58% |
| 64 | Whole market | +9.3% | 16.9% | 0.61 | −35.8% | +153% | 0.32 | 0.03% | |
| 65 | QUSState Street SPDR MSCI USA StrategicFactors ETF · Broad Market | Whole market | +11.1% | 14.2% | 0.81 | −33.8% | +273% | 0.43 | 0.15% |
| 66 | Whole market | +15.8% | 20.0% | 0.84 | −42.0% | +310% | 0.04 | — | |
| 67 | Whole market | +19.9% | 22.3% | 0.93 | −42.5% | +361% | 0.27 | — | |
| 68 | Whole market | +11.5% | 20.9% | 0.63 | −32.6% | +394% | 0.18 | — | |
| 69 | Whole market | +18.7% | 22.0% | 0.90 | −56.1% | +98.2% | 0.23 | — | |
| 70 | REGLProShares - S&P MidCap 400 Dividend Aristocrats ETF · Dividend & Income | Whole market | +7.2% | 16.0% | 0.52 | −36.4% | +148% | 0.31 | 0.40% |
| 71 | FTQIFirst Trust Nasdaq BuyWrite Income ETF · Dividend & Income | Whole market | +11.5% | 14.8% | 0.82 | −19.4% | +121% | 0.29 | 0.75% |
| 72 | Whole market | +15.7% | 20.4% | 0.82 | −42.6% | +248% | 0.17 | — | |
| 73 | Whole market | +17.8% | 21.4% | 0.88 | −53.7% | +140% | 0.20 | — | |
| 74 | EQLALPS Equal Sector Weight ETF · Broad Market | Whole market | +13.5% | 14.5% | 0.94 | −34.2% | +387% | 0.43 | 0.19% |
| 75 | Whole market | +22.7% | 24.4% | 0.97 | −50.5% | +341% | 0.32 | — | |
| 76 | Whole market | +19.2% | 21.6% | 0.93 | −47.3% | +395% | 0.17 | — | |
| 77 | Whole market | +6.8% | 17.6% | 0.47 | −39.4% | +198% | 0.35 | 0.03% | |
| 78 | Whole market | +22.4% | 22.3% | 1.02 | −46.3% | +347% | 0.27 | — | |
| 79 | FLOTiShares Floating Rate Bond ETF · Floating Rate Bonds | Whole market | +4.5% | 1.8% | 2.48 | −13.5% | +35.9% | 0.22 | 0.15% |
| 80 | Whole market | +13.6% | 21.4% | 0.71 | −51.0% | +295% | 0.08 | — | |
| 81 | Whole market | +9.8% | 25.2% | 0.50 | −39.4% | +60.7% | 0.35 | — | |
| 82 | QDEFNorthern Trust Quality Dividend Defensive ETF · Dividend & Income | Whole market | +12.7% | 13.7% | 0.94 | −35.7% | +228% | 0.41 | 0.40% |
| 83 | Whole market | +26.3% | 24.9% | 1.07 | −41.6% | +654% | 0.23 | — | |
| 84 | Whole market | +12.9% | 19.9% | 0.71 | −46.9% | +187% | 0.25 | — | |
| 85 | OUSAALPS Funds O’Shares U.S. Quality Dividend ETF · Dividend & Income | Whole market | +9.4% | 13.4% | 0.74 | −33.1% | +186% | 0.48 | 0.48% |
| 86 | Whole market | +2.7% | 2.9% | 0.94 | −6.3% | +32.7% | 0.31 | 0.03% | |
| 87 | FXUFirst Trust Utilities AlphaDEX Fund · Utilities | Whole market | +11.2% | 16.6% | 0.72 | −34.8% | +138% | 0.27 | 0.61% |
| 88 | Whole market | +7.1% | 22.9% | 0.42 | −38.7% | +295% | 0.18 | — | |
| 89 | Whole market | +6.2% | 20.6% | 0.40 | −42.0% | +179% | 0.28 | 0.03% | |
| 90 | Whole market | +17.2% | 24.9% | 0.77 | −30.4% | +285% | 0.02 | — | |
| 91 | Whole market | +18.7% | 22.5% | 0.88 | −55.1% | +163% | 0.25 | — | |
| 92 | Whole market | +11.1% | 24.2% | 0.56 | −36.7% | +204% | 0.17 | — | |
| 93 | Whole market | +10.3% | 16.2% | 0.69 | −34.2% | +223% | 0.35 | 0.06% | |
| 94 | Whole market | +16.5% | 23.1% | 0.78 | −48.4% | +808% | 0.46 | — | |
| 95 | Whole market | +6.8% | 19.4% | 0.44 | −38.7% | +122% | 0.06 | 0.09% | |
| 96 | Whole market | +5.2% | 17.5% | 0.38 | −36.4% | +102% | 0.13 | 0.06% | |
| 97 | Whole market | +5.2% | 8.9% | 0.61 | −25.4% | +37.8% | 0.08 | — | |
| 98 | Whole market | +11.2% | 20.8% | 0.62 | −37.4% | +319% | 0.31 | — | |
| 99 | Whole market | +12.9% | 20.8% | 0.69 | −51.6% | +184% | 0.32 | — | |
| 100 | Whole market | +19.0% | 20.8% | 0.95 | −54.9% | +335% | 0.35 | — |
BSX against its popular alternatives
The investments people most often weigh against BSX, compared period by period and year by year.
How do BSX's risk and return compare with its alternatives?
This map plots each investment's annual return over the past 5 years against its volatility, the size of its typical price swings. Investments toward the upper left earned more for a smoother ride, and those toward the lower right earned less for a rougher one. The dashed lines cross at BSX, which divides the map into what did better or worse on each measure.
- JNJ, SYK and BDX were both more rewarding and calmer than BSX over the past 5 years, earning a higher annual return with lower volatility.
- 12 of the 24 popular alternatives earned less than BSX over the past 5 years while swinging more, the weaker corner of the map.
- Over the past 5 years, BSX returned 0.5% a year, less than the S&P 500's 12.7%, with higher volatility (26.6% against 17.1%).
Green points earned more than BSX with less volatility; red points earned less with more. Hover over a point for its figures. Total returns with dividends reinvested, annualized.
All figures
| Investment | Annual return | Volatility |
|---|---|---|
| HCA HCA Healthcare, Inc. | +14.1% | 30.1% |
| JNJ Johnson & Johnson | +12.7% | 17.9% |
| SPY S&P 500State Street SPDR S&P 500 ETF | +12.7% | 17.1% |
| HAE Haemonetics Corporation | +10.7% | 41.0% |
| IRTC iRhythm Technologies, Inc. | +10.2% | 61.6% |
| ISRG Intuitive Surgical, Inc. | +5.2% | 34.6% |
| PEN Penumbra, Inc. | +3.5% | 40.4% |
| SYK Stryker Corporation | +3.2% | 25.7% |
| TMO Thermo Fisher Scientific Inc. | +2.9% | 27.8% |
| BDX Becton, Dickinson and Company | +2.3% | 24.1% |
| UNH UnitedHealth Group Incorporated | +1.1% | 32.1% |
| BSX This pageBoston Scientific Corporation | +0.5% | 26.6% |
| GMED Globus Medical, Inc. | +0.3% | 38.6% |
| LIVN LivaNova PLC | −0.4% | 39.6% |
| ABT Abbott Laboratories | −1.7% | 23.1% |
| MDT Medtronic Plc | −1.8% | 22.5% |
| ATEC Alphatec Holdings, Inc. | −2.4% | 63.5% |
| EW Edwards Lifesciences Corporation | −5.3% | 32.7% |
| ICUI ICU Medical, Inc. | −7.0% | 40.0% |
| ZBH Zimmer Biomet Holdings, Inc. | −7.2% | 27.2% |
| DXCM DexCom, Inc. | −9.2% | 47.3% |
| NVST Envista Holdings Corp | −10.0% | 36.4% |
| TFX Teleflex Incorporated | −18.2% | 34.5% |
| CNMD CONMED Corporation | −19.4% | 41.3% |
| INSP Inspire Medical Systems, Inc. | −22.3% | 61.0% |
| ENOV Enovis Corporation | −25.1% | 43.0% |
Has BSX consistently beaten its popular alternatives?
This section compares BSX with the investments people most often weigh against it, checking each one over eight periods from one month to ten years. Counting how often an alternative earned more than BSX helps separate lasting outperformance from a single strong stretch.
- 14 of the 25 popular alternatives, led by HCA, ISRG and HAE, outperformed BSX in at least 3 of 5 short-term and 2 of 3 long-term timeframes.
- HCA, ISRG and HAE outperformed BSX in every long-term period and in all but one short-term period, the most consistent record in the group.
- JNJ, HCA and ISRG earned more for the risk they took than BSX (a higher Sharpe ratio) and fell less in their worst decline of the past 10 years.
A green cell means the alternative earned more than BSX over that period. "Qualified" marks those that did so in at least 3 of 5 short-term periods and 2 of 3 long-term periods.
| Investment | Periods outperformed | Short term | Long term | Risk · 5 years | Fund | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Volatilitylower is calmer | Sharpehigher is better | Worst declinepast 10 years | Expense | Assets | Overlapsame sectors | ||
| BSX Boston Scientific Corporation (this page) | — | +4.3% | +4.1% | −25.3% | −51.9% | −54.7% | −8.9% | +2.5% | +98.1% | 26.6% | 0.15 | −61.6% | — | $66B | — |
| HCA QualifiedHCA Healthcare, Inc. | 5/5 short3/3 longAll-weather | +9.3% | +26.0% | −2.2% | −0.5% | +8.3% | +97.6% | +93.6% | +513% | 30.1% | 0.59 | −54.7% | — | $101B | — |
| ISRG QualifiedIntuitive Surgical, Inc. | 5/5 short3/3 longAll-weather | +9.0% | +24.0% | −5.9% | −22.1% | −4.5% | +64.1% | +28.9% | +478% | 34.6% | 0.32 | −49.9% | — | $155B | — |
| HAE QualifiedHaemonetics Corporation | 5/5 short3/3 longAll-weather | +8.7% | +51.2% | +93.2% | +47.8% | +133% | +32.7% | +66.5% | +241% | 41.0% | 0.45 | −68.6% | — | $5.4B | — |
| TMO QualifiedThermo Fisher Scientific Inc. | 4/5 short3/3 longAll-weather | +4.3% | +30.7% | +30.9% | +16.3% | +26.8% | +49.5% | +15.1% | +366% | 27.8% | 0.24 | −40.9% | — | $254B | — |
| SYK QualifiedStryker Corporation | 4/5 short3/3 longAll-weather | +11.4% | −4.3% | −9.5% | −11.8% | −19.2% | +18.0% | +17.2% | +197% | 25.7% | 0.25 | −43.8% | — | $117B | — |
| JNJ QualifiedJohnson & Johnson | 4/5 short3/3 longAll-weather | −3.8% | +4.8% | +13.6% | +27.1% | +36.9% | +84.6% | +82.1% | +196% | 17.9% | 0.76 | −27.4% | — | $625B | — |
| IRTC QualifiediRhythm Technologies, Inc. | 3/5 short3/3 long | +3.1% | +2.2% | −8.9% | −35.0% | −37.5% | +38.6% | +62.9% | +337% | 61.6% | 0.45 | −84.4% | — | $3.8B | — |
| PEN QualifiedPenumbra, Inc. | 3/5 short3/3 long | +1.7% | +2.0% | −1.6% | +4.8% | +31.0% | +57.8% | +18.5% | +333% | 40.4% | 0.28 | −62.6% | — | $13B | — |
| BDX QualifiedBecton, Dickinson and Company | 5/5 short2/3 long | +7.2% | +26.2% | +23.7% | +28.9% | +32.3% | +1.6% | +12.2% | +71.4% | 24.1% | 0.22 | −39.9% | — | $53B | — |
| DXCM QualifiedDexCom, Inc. | 4/5 short2/3 long | −3.8% | +13.3% | +32.7% | +28.9% | +25.3% | −0.3% | −38.4% | +316% | 47.3% | 0.04 | −66.3% | — | $32B | — |
| GMED QualifiedGlobus Medical, Inc. | 4/5 short2/3 long | +6.3% | +3.9% | −18.4% | −9.6% | +28.2% | +53.9% | +1.3% | +243% | 38.6% | 0.20 | −47.9% | — | $11B | — |
| UNH QualifiedUnitedHealth Group Incorporated | 4/5 short2/3 long | +11.0% | +0.1% | +31.2% | +27.1% | +18.1% | −15.3% | +5.5% | +241% | 32.1% | 0.20 | −61.4% | — | $376B | — |
| ABT QualifiedAbbott Laboratories | 3/5 short2/3 long | +0.3% | +1.6% | +8.4% | −15.3% | −18.7% | +13.0% | −8.0% | +204% | 23.1% | 0.04 | −39.6% | — | $178B | — |
| EW QualifiedEdwards Lifesciences Corporation | 3/5 short2/3 long | −0.1% | +3.9% | +8.4% | +3.5% | +17.3% | +27.1% | −23.6% | +125% | 32.7% | 0.01 | −54.3% | — | $51B | — |
| GEHC Medical - DevicesGE HealthCare Technologies Inc. | 5/5 short1/3 long | +8.4% | +11.8% | −5.2% | −15.1% | −6.8% | +10.1% | — | — | — | — | −37.4% | — | $32B | — |
| MDT Medical - DevicesMedtronic Plc | 4/5 short1/3 long | +4.0% | +14.5% | +13.3% | +1.0% | +1.9% | +43.6% | −8.8% | +46.7% | 22.5% | 0.03 | −45.1% | — | $121B | — |
| ZBH Medical - DevicesZimmer Biomet Holdings, Inc. | 4/5 short1/3 long | +2.1% | +7.3% | +1.1% | +7.5% | −5.6% | −5.5% | −31.1% | −16.1% | 27.2% | -0.14 | −52.1% | — | $18B | — |
| LIVN Medical - DevicesLivaNova PLC | 3/5 short1/3 long | +2.0% | +0.6% | +21.1% | +31.4% | +47.3% | +61.3% | −2.2% | +41.4% | 39.6% | 0.18 | −74.2% | — | $4.4B | — |
| ICUI Medical - Instruments & SuppliesICU Medical, Inc. | 3/5 short1/3 long | +3.8% | +2.4% | +23.4% | +16.3% | +37.3% | +49.0% | −30.5% | +12.5% | 40.0% | 0.02 | −73.8% | — | $4.0B | — |
| NVST Medical - Instruments & SuppliesEnvista Holdings Corp | 3/5 short1/3 long | −2.0% | −13.6% | −17.5% | +5.9% | +14.1% | −7.3% | −41.0% | — | 36.4% | -0.11 | −71.0% | — | $3.7B | — |
| ATEC Medical - DevicesAlphatec Holdings, Inc. | 5/5 short0/3 long | +6.8% | +31.3% | −6.0% | −47.7% | −29.9% | −11.3% | −11.4% | +81.6% | 63.5% | 0.28 | −81.8% | — | $1.7B | — |
| CNMD Medical - DevicesCONMED Corporation | 5/5 short0/3 long | +6.5% | +9.5% | +19.9% | +17.4% | −0.4% | −47.3% | −65.9% | +30.2% | 41.3% | -0.32 | −78.8% | — | $1.4B | — |
| TFX Medical - Instruments & SuppliesTeleflex Incorporated | 4/5 short0/3 long | +5.1% | −1.9% | −0.1% | +8.0% | +1.6% | −28.1% | −63.4% | −17.4% | 34.5% | -0.41 | −76.7% | — | $5.6B | — |
| ENOV Medical - DevicesEnovis Corporation | 4/5 short0/3 long | +14.7% | −22.9% | −21.2% | −22.0% | −36.2% | −53.5% | −76.4% | −59.0% | 43.0% | -0.46 | −80.9% | — | $1.2B | — |
| INSP Medical - DevicesInspire Medical Systems, Inc. | 4/5 short0/3 long | −5.8% | +33.9% | +25.2% | −22.7% | −11.7% | −54.3% | −71.6% | — | 61.0% | -0.10 | −87.7% | — | $2.1B | — |
How did BSX do year by year?
This table shows each investment's total return in every full calendar year since 1997, along with where BSX ranked among its popular alternatives each year. Annual results reveal how consistently each one kept pace with BSX and how far its good and bad years diverged, detail that multiyear averages tend to smooth over.
- Ranked against its popular alternatives each year, BSX finished in the top quarter in nine of 29 years and in the bottom quarter in 12. In 2025, it ranked 13 of 26.
- BSX finished ahead of the S&P 500 in ten of its 29 full calendar years.
- Among its popular alternatives, EW came out ahead of BSX most often, in 16 of the 25 years both traded.
Newest year first. Green marks a year in which the fund came out ahead of BSX; gray means the two finished within a fraction of a point. The rank row places BSX among the alternatives that traded the full year; dark green is the top quarter and red the bottom quarter.
| Investment | Years ahead of BSX | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX This pageBoston Scientific Corporation | — | +6.8% | +54.5% | +24.9% | +8.9% | +18.2% | −20.5% | +28.0% | +42.6% | +14.6% | +17.3% | +39.2% | +10.2% | +110% | +7.3% | −29.5% | −15.9% | +16.3% | −33.5% | −32.3% | −29.8% | −31.1% | −3.3% | +72.9% | +76.3% | +76.3% | −37.5% | −18.4% | +16.9% | −23.5% |
| Rank among alternatives | Top quarter in 9 of 29 | 13 of 26 | 4 of 26 | 3 of 26 | 3 of 25 | 14 of 25 | 25 of 25 | 13 of 24 | 4 of 23 | 20 of 23 | 9 of 22 | 2 of 20 | 16 of 20 | 2 of 20 | 16 of 19 | 16 of 18 | 17 of 18 | 10 of 18 | 9 of 17 | 17 of 17 | 15 of 16 | 15 of 15 | 14 of 15 | 1 of 15 | 1 of 15 | 2 of 13 | 11 of 11 | 7 of 11 | 9 of 11 | 10 of 11 |
| SPY S&P 500State Street SPDR S&P 500 ETF | 19 of 29 | +17.7% | +24.9% | +26.2% | −18.2% | +28.7% | +18.3% | +31.2% | −4.6% | +21.7% | +12.0% | +1.2% | +13.5% | +32.3% | +16.0% | +1.9% | +15.1% | +26.4% | −36.8% | +5.1% | +15.9% | +4.8% | +10.7% | +28.2% | −21.6% | −11.7% | −9.8% | +20.4% | +28.7% | +33.5% |
| HCA HCA Healthcare, Inc. | 6 of 14 | +56.7% | +11.8% | +13.8% | −5.6% | +57.6% | +11.6% | +20.2% | +43.4% | +18.7% | +9.4% | −7.8% | +53.8% | +58.1% | +70.9% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ISRG Intuitive Surgical, Inc. | 13 of 25 | +8.5% | +54.7% | +27.1% | −26.2% | +31.8% | +38.4% | +23.4% | +31.2% | +72.7% | +16.1% | +3.3% | +37.7% | −21.7% | +5.9% | +79.6% | −15.0% | +139% | −60.7% | +237% | −18.2% | +193% | +134% | +38.7% | −38.6% | +18.0% | — | — | — | — |
| HAE Haemonetics Corporation | 16 of 29 | +2.6% | −8.7% | +8.7% | +48.3% | −55.3% | +3.4% | +14.8% | +72.3% | +44.5% | +24.7% | −13.8% | −11.2% | +3.2% | +33.4% | −3.1% | +14.5% | −2.4% | −10.3% | +40.0% | −7.9% | +34.9% | +51.5% | +11.4% | −36.7% | +9.8% | +29.6% | +4.7% | +62.6% | −25.9% |
| TMO Thermo Fisher Scientific Inc. | 17 of 29 | +11.8% | −1.7% | −3.4% | −17.3% | +43.5% | +43.7% | +45.6% | +18.2% | +35.0% | −0.1% | +13.8% | +13.1% | +75.8% | +43.2% | −18.8% | +16.1% | +40.0% | −40.9% | +27.4% | +50.3% | −0.2% | +19.8% | +25.3% | −15.7% | +5.6% | +98.2% | −11.4% | −61.5% | +6.7% |
| SYK Stryker Corporation | 17 of 29 | −1.5% | +21.3% | +23.8% | −7.4% | +10.2% | +18.2% | +35.3% | +2.4% | +30.8% | +30.7% | 0.0% | +27.4% | +39.3% | +12.1% | −6.1% | +7.9% | +26.7% | −46.0% | +36.2% | +24.5% | −7.7% | +13.7% | +26.8% | +15.2% | +15.6% | +45.6% | +26.6% | +47.9% | +25.0% |
| JNJ Johnson & Johnson | 16 of 29 | +47.5% | −4.8% | −8.6% | +6.0% | +11.4% | +10.8% | +16.2% | −5.1% | +24.4% | +15.3% | +1.2% | +17.3% | +34.6% | +10.8% | +9.9% | −0.6% | +11.3% | −7.7% | +3.6% | +12.4% | −3.4% | +25.2% | −2.0% | −7.9% | +14.0% | +14.2% | +12.5% | +29.0% | +34.3% |
| IRTC iRhythm Technologies, Inc. | 3 of 9 | +96.8% | −15.8% | +14.3% | −20.4% | −50.4% | +248% | −2.0% | +24.0% | +86.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| PEN Penumbra, Inc. | 6 of 10 | +30.9% | −5.6% | +13.1% | −22.6% | +64.2% | +6.5% | +34.4% | +29.9% | +47.5% | +18.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BDX Becton, Dickinson and Company | 11 of 24 | −12.5% | −5.3% | −2.7% | +5.1% | +1.9% | −6.8% | +22.2% | +6.6% | +31.2% | +9.2% | +12.6% | +28.3% | +44.3% | +7.3% | −9.7% | +9.4% | +17.6% | −16.9% | +20.7% | +18.3% | +7.2% | +39.8% | +35.6% | −6.4% | — | — | — | — | — |
| DXCM DexCom, Inc. | 11 of 20 | −14.7% | −37.3% | +9.6% | −15.6% | +45.2% | +69.0% | +82.6% | +109% | −3.9% | −27.1% | +48.8% | +55.5% | +160% | +45.9% | −31.7% | +68.8% | +193% | −68.8% | −10.5% | −33.8% | — | — | — | — | — | — | — | — | — |
| GMED Globus Medical, Inc. | 4 of 13 | +5.6% | +55.2% | −28.2% | +2.9% | +10.7% | +10.8% | +36.0% | +5.3% | +65.7% | −10.8% | +17.0% | +17.8% | +92.4% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UNH UnitedHealth Group Incorporated | 15 of 29 | −33.1% | −2.4% | +0.8% | +6.9% | +45.2% | +21.3% | +20.0% | +14.5% | +39.8% | +38.4% | +18.3% | +36.5% | +41.0% | +8.6% | +42.2% | +19.9% | +14.8% | −54.3% | +8.3% | −13.5% | +41.2% | +51.4% | +39.4% | +18.1% | +15.3% | +131% | +23.5% | −13.4% | +10.3% |
| ABT Abbott Laboratories | 16 of 29 | +12.9% | +4.8% | +2.3% | −20.7% | +30.5% | +28.1% | +22.1% | +29.1% | +52.0% | −12.3% | +1.9% | +20.1% | +24.3% | +20.3% | +21.8% | −8.3% | +4.6% | −2.5% | +18.1% | +26.9% | −13.5% | +9.2% | +19.3% | −26.8% | +17.0% | +35.8% | −24.7% | +51.9% | +31.4% |
| EW Edwards Lifesciences Corporation | 16 of 25 | +15.2% | −2.9% | +2.2% | −42.4% | +42.0% | +17.3% | +52.3% | +35.9% | +20.3% | +18.6% | +24.0% | +93.7% | −27.1% | +27.6% | −12.6% | +86.1% | +58.1% | +19.6% | −2.3% | +13.0% | +0.9% | +37.0% | +18.4% | −7.8% | +55.4% | — | — | — | — |
| GEHC GE HealthCare Technologies Inc. | 1 of 3 | +5.1% | +1.3% | +32.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| MDT Medtronic Plc | 16 of 29 | +24.0% | +0.3% | +9.6% | −22.6% | −9.8% | +5.7% | +27.3% | +15.2% | +15.3% | −5.4% | +8.6% | +28.1% | +42.8% | +10.6% | +5.8% | −13.8% | +42.6% | −36.3% | −5.2% | −6.3% | +16.8% | +2.7% | +7.3% | −10.3% | −14.8% | +66.4% | −1.5% | +42.1% | +55.3% |
| ZBH Zimmer Biomet Holdings, Inc. | 12 of 24 | −14.0% | −12.5% | −3.8% | +4.3% | −17.0% | +3.8% | +45.4% | −13.3% | +17.9% | +1.5% | −8.8% | +22.8% | +41.2% | +26.2% | −0.5% | −9.2% | +46.3% | −38.9% | −15.6% | +16.2% | −15.8% | +13.8% | +69.6% | +35.9% | — | — | — | — | — |
| LIVN LivaNova PLC | 4 of 10 | +32.9% | −10.5% | −6.8% | −36.5% | +32.0% | −12.2% | −17.5% | +14.4% | +77.7% | −24.3% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ICUI ICU Medical, Inc. | 14 of 29 | −8.1% | +55.6% | −36.7% | −33.7% | +10.7% | +14.6% | −18.5% | +6.3% | +46.6% | +30.6% | +37.7% | +28.5% | +4.6% | +35.4% | +23.3% | +0.2% | +10.0% | −8.0% | −11.5% | +3.8% | +43.4% | −20.3% | −8.1% | +25.7% | +47.8% | +97.5% | −30.7% | +77.8% | +57.1% |
| NVST Envista Holdings Corp | 3 of 6 | +12.5% | −19.8% | −28.5% | −25.3% | +33.6% | +13.8% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| ATEC Alphatec Holdings, Inc. | 5 of 19 | +129% | −39.3% | +22.4% | +8.1% | −21.3% | +105% | +210% | −13.9% | −17.1% | −10.8% | −78.7% | −29.8% | +21.8% | −4.1% | −36.3% | −49.4% | +127% | −53.4% | +35.1% | — | — | — | — | — | — | — | — | — | — |
| CNMD CONMED Corporation | 16 of 29 | −40.0% | −36.8% | +24.5% | −37.0% | +27.4% | +1.2% | +75.7% | +27.4% | +17.3% | +2.2% | −0.4% | +7.8% | +55.0% | +11.2% | −2.9% | +15.9% | −4.8% | +3.6% | −0.1% | −2.3% | −16.7% | +19.4% | +21.5% | −1.9% | +162% | +32.4% | −21.6% | +25.8% | +28.0% |
| TFX Teleflex Incorporated | 16 of 29 | −30.7% | −28.2% | +0.5% | −23.6% | −19.9% | +9.8% | +46.3% | +4.5% | +55.4% | +23.7% | +15.7% | +23.9% | +33.8% | +18.9% | +16.6% | +2.3% | +10.7% | −18.6% | −0.7% | +1.1% | +27.1% | +9.5% | +14.8% | −8.1% | +8.6% | +43.6% | −30.6% | +22.2% | +46.8% |
| ENOV Enovis Corporation | 7 of 17 | −39.3% | −21.7% | +4.7% | −32.4% | +20.2% | +5.1% | +74.1% | −47.3% | +10.3% | +53.9% | −54.7% | −19.0% | +57.8% | +41.7% | +54.7% | +52.9% | +15.9% | — | — | — | — | — | — | — | — | — | — | — | — |
| INSP Inspire Medical Systems, Inc. | 4 of 7 | −50.2% | −8.9% | −19.2% | +9.5% | +22.3% | +153% | +75.6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Risk and diversification
How BSX has fallen, how it held up in crashes beside the S&P 500 and its popular alternatives, and what moves independently of it.
What were BSX's worst declines?
A drawdown is the decline from a peak to the lowest point before a new high. This section presents BSX's five deepest drawdowns since it began trading in 1992, alongside the S&P 500's return over the same dates, and how long each took to recover. Together, these figures show how much an investor could have lost and how long it took to get back to even.
- In all four of BSX's worst declines, the S&P 500 held up better over the same dates.
- Not every decline was the market's doing: BSX fell 89.1% from April 2004 to July 2012, while the S&P 500 rose 39.5%.
- The slowest recovery came after BSX fell 89.1% from April 2004 to July 2012; it did not regain that peak until August 2021, nine years later.
Green means BSX fell less than the S&P 500 over the same dates. Based on daily closing prices with dividends reinvested.
| During | BSX fell | S&P 500, same dates | Peak | Low | Time to the low | Back at the peak | Time to recover |
|---|---|---|---|---|---|---|---|
| 2008 financial crisis | −89.1% | +39.5% | Apr 2004 | Jul 2012 | 8.3 years | Aug 2021 | 9.1 years |
| Dot-com bust | −73.6% | −3.2% | Jul 1999 | Dec 2000 | 17 months | Mar 2003 | 2.3 years |
| No named crash | −61.6% | +21.4% | Sep 2025 | Oct 2026 | 13 months | Not yet | — |
| No named crash | −58.3% | — | Jan 1993 | Oct 1993 | 9 months | Mar 1995 | 17 months |
| No named crash | −47.8% | +3.3% | Aug 1998 | Nov 1998 | 3 months | Mar 1999 | 4 months |
How did BSX do in stock market crashes?
This section measures how far BSX, the S&P 500 and each alternative fell from peak to trough during every major market crash since 2000. A smaller decline means an investment held up better, and comparing results across crashes shows whether that resilience was consistent or a one-off.
- BSX fell further than the S&P 500 in eight of the ten crashes it has traded through. The clearest case was the dot-com bust, when BSX fell 56.7% and the S&P 500 fell 47.5%.
- Among its popular alternatives, JNJ held up best, falling less than BSX in eight of the ten crashes they both traded through.
Newest crash first. Each figure is the fund's deepest fall within the crash window; green means a smaller fall than BSX.
| Investment | Held up better | 2023 regional bank crisisMar 2023 | 2022 bear marketJan 2022 | Covid crashFeb 2020 | Late-2018 sell-offSep 2018 | February 2018 volatility shockFeb 2018 | 2015 China and oil sell-offAug 2015 | 2011 euro debt crisisJul 2011 | 2010 flash crashMay 2010 | 2008 financial crisisOct 2007 | Dot-com bustMar 2000 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX This pageBoston Scientific Corporation | — | −1.2% | −25.2% | −40.0% | −18.7% | −8.0% | −15.2% | −24.0% | −3.2% | −63.5% | −56.7% |
| SPY S&P 500State Street SPDR S&P 500 ETF | 8 of 10 | −3.4% | −24.5% | −33.7% | −19.3% | −6.5% | −12.8% | −17.9% | −1.5% | −55.2% | −47.5% |
| HCA HCA Healthcare, Inc. | 1 of 7 | −2.2% | −39.5% | −54.4% | −20.6% | −3.8% | −31.3% | −49.0% | — | — | — |
| ISRG Intuitive Surgical, Inc. | 1 of 9 | −2.7% | −47.6% | −40.5% | −24.3% | −8.4% | −14.7% | −20.6% | −3.8% | −75.9% | — |
| HAE Haemonetics Corporation | 7 of 10 | −5.1% | −22.8% | −38.3% | −22.3% | −4.3% | −24.6% | −18.9% | −0.9% | −24.2% | −54.7% |
| TMO Thermo Fisher Scientific Inc. | 5 of 10 | −2.4% | −19.8% | −24.8% | −17.2% | −8.7% | −14.7% | −24.4% | −3.6% | −53.9% | −41.8% |
| SYK Stryker Corporation | 3 of 10 | −1.4% | −31.4% | −43.8% | −18.8% | −8.8% | −15.6% | −23.0% | −3.8% | −58.6% | −26.9% |
| JNJ Johnson & Johnson | 8 of 10 | −1.1% | −12.7% | −25.4% | −16.9% | −8.2% | −9.0% | −9.8% | −0.1% | −34.4% | −35.9% |
| IRTC iRhythm Technologies, Inc. | 1 of 5 | −9.9% | −35.8% | −43.0% | −36.9% | −0.8% | — | — | — | — | — |
| PEN Penumbra, Inc. | 2 of 5 | −2.1% | −58.0% | −35.8% | −27.5% | −7.2% | — | — | — | — | — |
| BDX Becton, Dickinson and Company | 5 of 9 | −2.0% | −19.7% | −21.8% | −20.4% | −10.8% | −15.1% | −18.3% | −1.6% | −34.1% | — |
| DXCM DexCom, Inc. | 2 of 9 | −4.4% | −48.8% | −36.8% | −27.8% | −5.1% | −47.6% | −33.2% | −6.1% | −87.0% | — |
| GMED Globus Medical, Inc. | 2 of 6 | −5.9% | −34.8% | −38.0% | −28.0% | −5.1% | −23.6% | — | — | — | — |
| UNH UnitedHealth Group Incorporated | 7 of 10 | −1.8% | −16.9% | −35.9% | −18.6% | −6.7% | −12.4% | −20.7% | −0.8% | −72.4% | −19.8% |
| ABT Abbott Laboratories | 6 of 10 | −2.5% | −27.9% | −29.7% | −11.7% | −8.8% | −27.4% | −11.5% | −0.5% | −22.3% | −45.7% |
| EW Edwards Lifesciences Corporation | 6 of 9 | −3.8% | −36.0% | −33.2% | −20.0% | −6.1% | −9.7% | −19.4% | −2.4% | −31.9% | — |
| GEHC GE HealthCare Technologies Inc. | 0 of 1 | −2.2% | — | — | — | — | — | — | — | — | — |
| MDT Medtronic Plc | 7 of 10 | −2.1% | −27.9% | −36.0% | −13.8% | −7.2% | −17.6% | −18.0% | −1.5% | −56.5% | −44.2% |
| ZBH Zimmer Biomet Holdings, Inc. | 5 of 9 | 0.0% | −23.9% | −49.6% | −26.0% | −8.2% | −14.8% | −20.3% | −2.1% | −62.0% | — |
| LIVN LivaNova PLC | 1 of 5 | −6.3% | −49.0% | −55.3% | −32.9% | −5.0% | — | — | — | — | — |
| ICUI ICU Medical, Inc. | 5 of 10 | −1.9% | −43.5% | −26.0% | −24.6% | −6.1% | −29.8% | −16.3% | −4.0% | −43.9% | −38.6% |
| NVST Envista Holdings Corp | 0 of 3 | −3.3% | −36.3% | −57.9% | — | — | — | — | — | — | — |
| ATEC Alphatec Holdings, Inc. | 1 of 9 | −10.1% | −51.4% | −66.8% | −36.0% | −1.3% | −72.9% | −41.4% | −3.4% | −82.1% | — |
| CNMD CONMED Corporation | 2 of 10 | −6.1% | −50.9% | −62.1% | −28.1% | −6.3% | −35.9% | −26.0% | −3.9% | −64.6% | −42.2% |
| TFX Teleflex Incorporated | 6 of 10 | −2.6% | −47.2% | −42.9% | −16.7% | −8.5% | −10.8% | −21.6% | −0.5% | −42.8% | −29.5% |
| ENOV Enovis Corporation | 1 of 8 | −5.1% | −44.5% | −62.4% | −47.4% | −17.3% | −53.6% | −31.8% | −0.2% | — | — |
| INSP Inspire Medical Systems, Inc. | 0 of 4 | −9.6% | −44.7% | −53.7% | −29.5% | — | — | — | — | — | — |
How closely does BSX move with the S&P 500?
Upside capture measures how much of the S&P 500's gains an investment kept in the months the market rose, and downside capture how much of its losses it took in the months the market fell. An investment that captures more of the gains than the losses has compounded ahead of the market over time. This section compares BSX with its popular alternatives on both measures, and on beta (how strongly each has moved with the market), over the past 10 years.
- 12 of the 21 popular alternatives had a higher capture ratio (upside capture divided by downside capture) than BSX's 0.70, led by PEN, HAE and JNJ.
- PEN took just 40% of the S&P 500's losses, against 109% for BSX, while still keeping 70% of its gains.
- Over the past 10 years, BSX captured 76% of the S&P 500's gains in rising months and 109% of its losses in falling months, with a beta of 0.72. Its share of the market's losses was larger than its share of the gains.
Monthly total returns over the past 10 years, measured against SPY. 100% capture or a beta of 1.00 means moving in line with the S&P 500. Green marks a better figure than BSX's: more upside, less downside or a higher capture ratio. Sorted by capture ratio.
| Investment | Upside capture | Downside capture | Capture ratio | Beta |
|---|---|---|---|---|
| BSX This pageBoston Scientific Corporation | 76% | 109% | 0.70 | 0.72 |
| PEN Penumbra, Inc. | 70% | 40% | 1.72 | 0.52 |
| HAE Haemonetics Corporation | 62% | 51% | 1.22 | 0.47 |
| JNJ Johnson & Johnson | 64% | 53% | 1.20 | 0.46 |
| TMO Thermo Fisher Scientific Inc. | 104% | 104% | 1.00 | 0.81 |
| DXCM DexCom, Inc. | 97% | 97% | 1.00 | 1.13 |
| UNH UnitedHealth Group Incorporated | 81% | 82% | 0.98 | 0.70 |
| HCA HCA Healthcare, Inc. | 135% | 140% | 0.97 | 1.37 |
| ABT Abbott Laboratories | 76% | 79% | 0.96 | 0.64 |
| ISRG Intuitive Surgical, Inc. | 136% | 154% | 0.88 | 1.28 |
| SYK Stryker Corporation | 82% | 96% | 0.86 | 0.88 |
| GMED Globus Medical, Inc. | 118% | 148% | 0.80 | 1.03 |
| EW Edwards Lifesciences Corporation | 88% | 120% | 0.73 | 0.97 |
| BDX Becton, Dickinson and Company | 53% | 77% | 0.69 | 0.48 |
| MDT Medtronic Plc | 62% | 105% | 0.59 | 0.68 |
| LIVN LivaNova PLC | 74% | 129% | 0.57 | 0.89 |
| ICUI ICU Medical, Inc. | 78% | 136% | 0.57 | 0.69 |
| CNMD CONMED Corporation | 90% | 159% | 0.57 | 1.25 |
| ATEC Alphatec Holdings, Inc. | 63% | 117% | 0.54 | 1.28 |
| TFX Teleflex Incorporated | 79% | 170% | 0.47 | 1.01 |
| ZBH Zimmer Biomet Holdings, Inc. | 62% | 139% | 0.44 | 0.88 |
| ENOV Enovis Corporation | 95% | 252% | 0.38 | 1.65 |
What diversifies BSX?
Correlation measures how closely two investments move together, on a scale from 1 (in lockstep) through 0 (unrelated) to -1 (in opposite directions). This section lists large ETFs and stocks whose returns have had a low correlation with BSX's. Because such investments tend not to fall at the same time, pairing BSX with them can reduce a portfolio's overall swings.
- Moving a fifth of the money in BSX into DXJ would have cut the portfolio's volatility by 18% over the past 5 years and raised its annual return (+0.1% for BSX alone, +5.6% for the mix).
- Among large ETFs, LVHI, DXJ and EMLP have moved largely independently of BSX over the past 5 years, with correlations of 0.34 or lower, and each still earned a positive 5-year return.
- GLD made money in seven of the 11 calendar years in which BSX lost money.
Only ETFs with at least $1.0B in assets and stocks worth at least $10B, with a correlation below 0.5 over the past 5 years and a positive return, are included, ranked by Sharpe ratio; funds that hold the same thing are shown once. The year columns are the years in which BSX lost money. The last two columns show a portfolio that is 80% BSX and 20% the other investment, rebalanced monthly.
ETFs
| Investment | Correlation | 5Y return | Sharpe | 2020 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2000 | 1999 | 1997 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX Boston Scientific Corporation (this page) | 1.00 | +2.5% | 0.15 | −20.5% | −29.5% | −15.9% | −33.5% | −32.3% | −29.8% | −31.1% | −3.3% | −37.5% | −18.4% | −23.5% | 24.5% | +0.1% |
| LVHI InternationalFranklin International Low Volatility High Dividend Index ETF | 0.29 | +119% | 1.48 | −9.0% | — | — | — | — | — | — | — | — | — | — | 20.2% | +3.8% |
| DXJ InternationalWisdomTree Japan Hedged Equity Fund | 0.17 | +225% | 1.34 | +3.9% | −16.1% | −1.8% | −20.8% | −7.4% | — | — | — | — | — | — | 20.2% | +5.6% |
| EMLP Broad MarketFirst Trust North American Energy Infrastructure Fund | 0.34 | +101% | 1.04 | −13.4% | — | — | — | — | — | — | — | — | — | — | 20.8% | +3.5% |
| HDV Dividend & IncomeiShares Core High Dividend ETF | 0.38 | +83.3% | 1.00 | −6.5% | — | — | — | — | — | — | — | — | — | — | 20.8% | +2.9% |
| SMH TechnologyVanEck Semiconductor ETF | -0.01 | +323% | 0.97 | +55.5% | +6.8% | +19.0% | −44.7% | +6.0% | −6.7% | +10.8% | −19.3% | — | — | — | 20.7% | +8.3% |
| DBEF InternationalXtrackers MSCI EAFE Hedged Equity ETF | 0.34 | +85.0% | 0.96 | +2.1% | — | — | — | — | — | — | — | — | — | — | 20.5% | +3.2% |
| GLD CommoditiesSPDR Gold Shares | 0.23 | +126% | 0.96 | +24.8% | +9.6% | +29.3% | +4.9% | +30.4% | +22.6% | +17.8% | — | — | — | — | 20.7% | +4.1% |
| SPMO Broad MarketInvesco S&P 500 Momentum ETF | 0.20 | +136% | 0.93 | +28.2% | — | — | — | — | — | — | — | — | — | — | 20.8% | +4.8% |
Stocks
| Investment | Correlation | 5Y return | Sharpe | 2020 | 2011 | 2010 | 2008 | 2007 | 2006 | 2005 | 2004 | 2000 | 1999 | 1997 | 80/20 mix volatility | 80/20 mix annual return |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BSX Boston Scientific Corporation (this page) | 1.00 | +2.5% | 0.15 | −20.5% | −29.5% | −15.9% | −33.5% | −32.3% | −29.8% | −31.1% | −3.3% | −37.5% | −18.4% | −23.5% | 24.5% | +0.1% |
| CAH Medical - DistributionCardinal Health, Inc. | 0.32 | +479% | 1.55 | +10.1% | +8.1% | +21.4% | −39.6% | −9.8% | −5.8% | +18.7% | −4.7% | +108% | −36.8% | +29.1% | 21.9% | +7.5% |
| CLS Hardware, Equipment & PartsCelestica Inc. | 0.19 | +3,143% | 1.47 | −2.4% | −24.4% | +2.8% | −20.5% | −25.7% | −26.0% | −25.2% | −6.4% | −2.3% | +350% | — | 24.6% | +19.4% |
| FIX Engineering & ConstructionComfort Systems USA, Inc. | 0.05 | +1,636% | 1.46 | +6.7% | −17.0% | +8.7% | −15.2% | +2.1% | +38.9% | +20.1% | +40.0% | −71.1% | −58.7% | — | 22.0% | +16.0% |
| MCK Medical - DistributionMcKesson Corporation | 0.29 | +413% | 1.44 | +27.1% | +11.8% | +13.8% | −40.4% | +29.7% | −1.2% | +64.9% | −1.4% | +61.2% | −71.3% | +96.3% | 21.6% | +7.0% |
| MPC Oil & Gas Refining & MarketingMarathon Petroleum Corporation | 0.11 | +690% | 1.41 | −27.4% | — | — | — | — | — | — | — | — | — | — | 21.3% | +9.7% |
Common questions
What was BSX's worst drawdown?
BSX's deepest decline since it began trading in 1992 was 89.1%, from April 2004 to July 2012. It took about nine years from the low to climb back to its old high.
What were BSX's best and worst years?
Over 29 full calendar years, BSX's best year was 2013, when it returned 110%. Its worst was 2000, with a return of -37.5%.
Is there a better investment than BSX?
Among BSX's popular alternatives, JNJ and BDX earned more than BSX with less volatility over the past 5 years. JNJ returned 12.7% a year at 17.9% volatility, against 0.5% a year at 26.6%. Looking beyond its popular alternatives, CAH (health care distribution) and ABBV (pharmaceuticals) earned more than BSX with less volatility over the past 5 years. CAH returned 42.1% a year at 24.7% volatility, against 0.5% a year at 26.6%.
Is BSX more volatile than the S&P 500?
Yes. BSX's volatility over the past 5 years was 26.6%, 1.5 times the S&P 500's 17.1%. Volatility measures how widely returns swing around their average: in roughly two years out of three, BSX's return lands within 26.6% of its average, either way. The higher it is, the rougher the ride and the harder it is to hold through a slump.
What is BSX's Sharpe ratio?
BSX's Sharpe ratio over the past 5 years was 0.15, against 0.79 for the S&P 500, so BSX earned less for each unit of risk than an index fund did. The Sharpe ratio is the return earned above cash for each unit of volatility: two investments with the same return are not equal if one got there with far bigger swings.
How correlated is BSX with the S&P 500?
Over the past 5 years, BSX's monthly returns had a correlation of 0.37 with the S&P 500. Correlation runs from 1 (moving in lockstep) through 0 (unrelated) to −1 (moving in opposite directions). They are only loosely linked, which makes it a real diversifier next to an index fund. In the table, the correlation column measures each option against BSX instead: the lower it is, the more that option would diversify a BSX holding.
What are the best alternatives to BSX?
Of the 25 popular alternatives we compared, 14 outperformed BSX in at least 3 of 5 short-term and 2 of 3 long-term timeframes, with dividends reinvested: HCA, ISRG and HAE.
Did BSX outperform the S&P 500?
BSX finished ahead of the S&P 500 (SPY) in ten of 29 full calendar years. In 2025, it returned +6.8%, against +17.7% for the index.
How did BSX do in stock market crashes?
BSX fell less than the S&P 500 (SPY) in two of the ten major crashes it has traded through, and further in eight. The clearest case was the dot-com bust, when BSX fell 56.7% and the S&P 500 fell 47.5%.
What diversifies BSX?
These had a low correlation with BSX over the past 5 years and still earned a positive 5-year return: among large ETFs, LVHI (correlation 0.29), DXJ (correlation 0.17) and EMLP (correlation 0.34); among large stocks, CAH (correlation 0.32), CLS (correlation 0.19) and FIX (correlation 0.05). A correlation near zero means the two have moved largely independently.
How we measure
- Short-term periods are 1M, 3M, 6M, YTD, 1Y; long-term periods are 3Y, 5Y, 10Y. An investment outperformed in a period when its total return, with dividends reinvested, was higher than BSX's. Returns within 0.5 points or 3% of BSX's, whichever is larger, count as a tie.
- "Qualified" means outperforming in at least 3 of 5 short-term periods and 2 of 3 long-term periods. "All-weather" means outperforming in every long-term period and all but one short-term period.
- Popular alternatives are the funds and stocks most often compared with this one. We include only those that trade today, are not leveraged or inverse, and hold at least $200 million.
- Volatility is the annualized standard deviation of daily returns over 5 years, a measure of how much the price typically swings in a year. The Sharpe ratio is the return above cash for each unit of that volatility.
- A decline, or drawdown, runs from a peak to the lowest close before the next high. The worst decline ever uses all the price history we have; comparisons between funds use the past 10 years so that younger funds are judged on the same stretch.
- Sector overlap is the share of assets two funds hold in the same sectors. Correlation and the mixed-portfolio figures use monthly returns.
- Upside and downside capture follow Morningstar's definition: the compound monthly return in the months the S&P 500 rose (or fell), divided by the S&P 500's compound return in those months. Beta measures how strongly monthly returns have moved with the S&P 500. All three use the same window for every investment.
- Figures are computed from daily adjusted prices and update after each trading day. Past performance does not predict future results.
More research
Popular alternatives to BSX
HCAHCA Healthcare
ISRGIntuitive Surgical
TMOThermo Fisher Scientific
SYKStryker
JNJJohnson & Johnson
BDXBecton, Dickinson and Company
UNHUnitedHealth Group
ABTAbbott Laboratories
EWEdwards Lifesciences
MDTMedtronic